Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
UK: Narayana Health expands global footprint with UK-based Practice Plus Group Hospitals
Narayana Health, an India-headquartered global healthcare provider, has moved into the UK healthcare market with the acquisition of Practice Plus Group Hospitals for a reported £188.78m (US$248m). The acquisition extends […]
Narayana Health, an India-headquartered global healthcare provider, has moved into the UK healthcare market with the acquisition of Practice Plus Group Hospitals for a reported £188.78m (US$248m). The acquisition extends […]
UK: Narayana Health expands global footprint with UK-based Practice Plus Group Hospitals
October 31, 2025
Healthcare
Hospitals and Clinics
M&A
News
Baird
Germany: Tubulis announces second closing of Series C
Tubulis has held the final close of its recently announced first close of its massive Series C at €344m (US$397m). The round welcomed additional new investors Fidelity Management and Research […]
Tubulis has held the final close of its recently announced first close of its massive Series C at €344m (US$397m). The round welcomed additional new investors Fidelity Management and Research […]
Germany: Tubulis announces second closing of Series C
October 31, 2025
Life Sciences
News
Pharma
Venture
Blackstone
Switzerland: Oculis prices US$110m financing to accelerate development of Privosegtor
Oculis Holding, a listed global biopharmaceutical company focused on innovations to address unmet medical needs in ophthalmology and neuro-ophthalmology, has priced an oversubscribed US$110m financing to accelerate Privosegtor development. The […]
Oculis Holding, a listed global biopharmaceutical company focused on innovations to address unmet medical needs in ophthalmology and neuro-ophthalmology, has priced an oversubscribed US$110m financing to accelerate Privosegtor development. The […]
Switzerland: Oculis prices US$110m financing to accelerate development of Privosegtor
October 30, 2025
News
Pharma
Public Equity
Arctica Finance
JP Morgan
Investing in women’s health: growth, innovation and the next wave of FemTech opportunities
Long overlooked by mainstream investors, women’s health is finally attracting serious attention. With sustained growth, rising consumer demand, and a shift toward preventive and personalised care, women’s health and FemTech […]
Long overlooked by mainstream investors, women’s health is finally attracting serious attention. With sustained growth, rising consumer demand, and a shift toward preventive and personalised care, women’s health and FemTech […]
Investing in women’s health: growth, innovation and the next wave of FemTech opportunities
October 30, 2025
Analysis
Articles
Healthcare
Life Sciences
Pharma
US: Thermo Fisher Scientific to acquire Clario from Astorg, Nordic Capital, Novo Holdings and Cinven for up to US$9.4bn
New York-listed Thermo Fisher Scientific, a world leader in life science and clinical research, is to acquire US-based Clario Holdings, a provider of endpoint data solutions to the clinical trial […]
New York-listed Thermo Fisher Scientific, a world leader in life science and clinical research, is to acquire US-based Clario Holdings, a provider of endpoint data solutions to the clinical trial […]
US: Thermo Fisher Scientific to acquire Clario from Astorg, Nordic Capital, Novo Holdings and Cinven for up to US$9.4bn
October 30, 2025
M&A
News
Pharma
Services – CRO/CMO/CDMO
Astorg
Netherlands: Ottobock strengthens role as largest shareholder in Onward Medical following private placement
Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, last week raised €50.85m (US$59.2m) through a private […]
Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, last week raised €50.85m (US$59.2m) through a private […]
Netherlands: Ottobock strengthens role as largest shareholder in Onward Medical following private placement
October 29, 2025
Life Sciences
Medtech – Medical Devices and Implants
News
Public Equity
a.s.r. Asset Management
France: Archimed Diagnostics closes acquisition of ARK Diagnostics
Archimed Diagnostics has closed its carve-out of US-based ARK Diagnostics from listed South Korean specialty chemical company, Soulbrain Holdings. ARK is a global developer and manufacturer of specialty immunoassay In […]
Archimed Diagnostics has closed its carve-out of US-based ARK Diagnostics from listed South Korean specialty chemical company, Soulbrain Holdings. ARK is a global developer and manufacturer of specialty immunoassay In […]
France: Archimed Diagnostics closes acquisition of ARK Diagnostics
October 29, 2025
Buy Out
IVD – Tools
Life Sciences
M&A
Medtech – Diagnostics
Switzerland: EQT, ADIA and Auba sell another 8.4% of Galderma
EQT, ADIA and Auba have sold another 8.4% of their holding in Switzerland-based skincare specialist in an overnight share sale, say reports. Bloomberg reports that the trio sold 20 million […]
EQT, ADIA and Auba have sold another 8.4% of their holding in Switzerland-based skincare specialist in an overnight share sale, say reports. Bloomberg reports that the trio sold 20 million […]
Switzerland: EQT, ADIA and Auba sell another 8.4% of Galderma
October 28, 2025
Cosmetic & Aesthetics
Healthcare
News
Public Equity
BoA Securities
Switzerland: Cicor Group strengthens medical technology business with acquisition of two sites from Valtronic
SIX Swiss-listed The Cicor Group, a Switzerland-based, globally active provider of full-cycle electronic solutions from R&D to manufacturing and supply chain management, is strengthening its medical technology business with the […]
SIX Swiss-listed The Cicor Group, a Switzerland-based, globally active provider of full-cycle electronic solutions from R&D to manufacturing and supply chain management, is strengthening its medical technology business with the […]
Switzerland: Cicor Group strengthens medical technology business with acquisition of two sites from Valtronic
October 28, 2025
Life Sciences
M&A
Medtech – Diagnostics
News
Pharma
UK: Welltower invests £6.4bn in UK senior care homes
New York-listed Welltower, a healthcare infrastructure investor focusing on rental housing for aging seniors across the US, UK, and Canada, has announced US$14bn of acquisitions, primarily comprised of high-quality seniors housing communities in the […]
New York-listed Welltower, a healthcare infrastructure investor focusing on rental housing for aging seniors across the US, UK, and Canada, has announced US$14bn of acquisitions, primarily comprised of high-quality seniors housing communities in the […]
UK: Welltower invests £6.4bn in UK senior care homes
October 28, 2025
Care Homes
M&A
M&A Deals
News
Real Assets
UK: GHO Capital announces final close of Fund IV with over €2.5bn of capital
GHO Capital, a European specialist investor in global healthcare, has announces the final close of its fourth fund, GHO Capital IV, raising over €2.5bn (US$2.9bn) of capital available to invest. […]
GHO Capital, a European specialist investor in global healthcare, has announces the final close of its fourth fund, GHO Capital IV, raising over €2.5bn (US$2.9bn) of capital available to invest. […]
UK: GHO Capital announces final close of Fund IV with over €2.5bn of capital
October 28, 2025
Buy Out
Healthcare
Life Sciences
News
Pharma
UK: Mansfield Advisors builds out Animal Health and Pharma & Life Sciences franchise with appointment of James Andrews
Mansfield Advisors, a UK-based strategy consulting firm across healthcare, life sciences and veterinary, has appointed James Andrews as partner as it builds out its Animal Health and Pharma & Life […]
Mansfield Advisors, a UK-based strategy consulting firm across healthcare, life sciences and veterinary, has appointed James Andrews as partner as it builds out its Animal Health and Pharma & Life […]
UK: Mansfield Advisors builds out Animal Health and Pharma & Life Sciences franchise with appointment of James Andrews
October 27, 2025
Education
Healthcare
Life Sciences
News
People
Switzerland: Novartis to acquire Avidity Biosciences at total equity value of US$12bn
Switzerland-based multi-national pharmaceutical company Novartis has entered into an agreement to acquire Avidity Biosciences, a US-based biopharmaceutical company, for US$72.00 per share (a 46% premium) in cash for total equity value of […]
Switzerland-based multi-national pharmaceutical company Novartis has entered into an agreement to acquire Avidity Biosciences, a US-based biopharmaceutical company, for US$72.00 per share (a 46% premium) in cash for total equity value of […]
Switzerland: Novartis to acquire Avidity Biosciences at total equity value of US$12bn
October 27, 2025
Life Sciences
M&A
News
Pharma
Avidity Biosciences
Germany: FIM Medical becomes leading developer and distributor of European occupational healthcare devices with purchase of Vistec
FIM Medical, a prominent player in the French occupational health medical device market, has acquired Vistec, a Germany-based specialist in vision screening devices for the occupational health sector, from social investor […]
FIM Medical, a prominent player in the French occupational health medical device market, has acquired Vistec, a Germany-based specialist in vision screening devices for the occupational health sector, from social investor […]
Germany: FIM Medical becomes leading developer and distributor of European occupational healthcare devices with purchase of Vistec
October 24, 2025
Buy Out
Consumer Healthcare
Digital Health/Healthtech
Healthcare
M&A
Switzerland: EssilorLuxottica accelerates AI driven eye health solutions with acquisition of RetinAI
EssilorLuxottica, a France-based global designer, manufacturer and distributer of advanced vision care products, eyewear and med-tech solutions, has acquired Switzerland-based Ikerian, a health tech company, operating under the RetinAI brand, […]
EssilorLuxottica, a France-based global designer, manufacturer and distributer of advanced vision care products, eyewear and med-tech solutions, has acquired Switzerland-based Ikerian, a health tech company, operating under the RetinAI brand, […]
Switzerland: EssilorLuxottica accelerates AI driven eye health solutions with acquisition of RetinAI
October 23, 2025
Healthcare
Life Sciences
M&A
Medtech – Hospital Equipment
News
Germany: Soenke Roessing appointed as CEO of Meyra Group
Meyra Group, a Germany-based provider of mobility and rehabilitation solutions, has appointed Dr Soenke Roessing as CEO. He will assume the role on 1 November. Roessing brings extensive industry and […]
Meyra Group, a Germany-based provider of mobility and rehabilitation solutions, has appointed Dr Soenke Roessing as CEO. He will assume the role on 1 November. Roessing brings extensive industry and […]
Germany: Soenke Roessing appointed as CEO of Meyra Group
October 23, 2025
Life Sciences
Medtech – Medical Devices and Implants
News
People
Germany
Australia: ENA Respiratory attracts US$22.4m to fund Phase II development of INNA-051 nasal spray
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of symptomatic viral respiratory infections, has raised US$22.4m in its Series B financing. New investment was received from […]
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of symptomatic viral respiratory infections, has raised US$22.4m in its Series B financing. New investment was received from […]
Australia: ENA Respiratory attracts US$22.4m to fund Phase II development of INNA-051 nasal spray
October 22, 2025
Life Sciences
News
Venture
Australia
Brandon Capital
Netherlands: Forbion elevates Mathias Vinther to partner within its Growth Fund
Netherlands-based venture capital investor, Forbion, has promoted Mathias Vinther to partner within its Growth Fund. Vinther joined Forbion in March 2022 as principal, and has been instrumental in the evaluation, […]
Netherlands-based venture capital investor, Forbion, has promoted Mathias Vinther to partner within its Growth Fund. Vinther joined Forbion in March 2022 as principal, and has been instrumental in the evaluation, […]
Netherlands: Forbion elevates Mathias Vinther to partner within its Growth Fund
October 22, 2025
Life Sciences
News
People
Venture
Forbion
France: Ipsen to strengthen oncology pipeline with ImCheck Therapeutics
Global biopharmaceutical company, Paris-listed Ipsen, has agreed to acquire ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies. Under the terms of the agreement, shareholders of ImCheck Therapeutics will […]
Global biopharmaceutical company, Paris-listed Ipsen, has agreed to acquire ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies. Under the terms of the agreement, shareholders of ImCheck Therapeutics will […]
France: Ipsen to strengthen oncology pipeline with ImCheck Therapeutics
October 22, 2025
M&A
Manufacturing – Specialty Pharma
News
Pharma
Agent Capital
Belgium: Insta strengthens presence in PDMP market with acquisition of Prothya Biosolutions
Accord Healthcare’s Accord Plasma, a subsidiary of Indian multinational pharma Intas Pharmaceuticals, has completed the acquisition of Prothya Biosolutions Belgium and its subsidiaries. The move marks a significant step in […]
Accord Healthcare’s Accord Plasma, a subsidiary of Indian multinational pharma Intas Pharmaceuticals, has completed the acquisition of Prothya Biosolutions Belgium and its subsidiaries. The move marks a significant step in […]
Belgium: Insta strengthens presence in PDMP market with acquisition of Prothya Biosolutions
October 21, 2025
IVD – Tools
Life Sciences
M&A
News
Accord Plasma
Germany: NextPharma to sell logistics arm to Cencora as it pivots to pure-play CDMO strategy
Germany-based NextPharma, is selling its healthcare logistics services business, NextPharma Logistics, to US-based listed global pharmaceutical solutions organisation Cencora. “We are excited by the opportunities of further developing and growing […]
Germany-based NextPharma, is selling its healthcare logistics services business, NextPharma Logistics, to US-based listed global pharmaceutical solutions organisation Cencora. “We are excited by the opportunities of further developing and growing […]
Germany: NextPharma to sell logistics arm to Cencora as it pivots to pure-play CDMO strategy
October 21, 2025
Distribution
Healthcare
M&A
News
CapVest
France: MxEP strengthens in healthcare and technology with Emna Bourkhis appointment
Mérieux Equity Partners has appointed Emna Bourkhis as director in its Buyout Investment team, strengthening its expertise in healthcare and technology investments. She is based in the Paris office, reporting […]
Mérieux Equity Partners has appointed Emna Bourkhis as director in its Buyout Investment team, strengthening its expertise in healthcare and technology investments. She is based in the Paris office, reporting […]
France: MxEP strengthens in healthcare and technology with Emna Bourkhis appointment
October 21, 2025
Healthcare
Life Sciences
News
People
Emna Bourkhis
France: Archimed completes US$750m take-private of ZimVie
France-based healthcare specialist investor Archimed has completed the take-private acquisition of Nasdaq-listed ZimVie private. ZimVie, a US-based global dental technology company that develops, manufactures, and distributes regenerative biomaterials, premium implants […]
France-based healthcare specialist investor Archimed has completed the take-private acquisition of Nasdaq-listed ZimVie private. ZimVie, a US-based global dental technology company that develops, manufactures, and distributes regenerative biomaterials, premium implants […]
France: Archimed completes US$750m take-private of ZimVie
October 21, 2025
Buy Out
Dental
Healthcare
M&A
News
IIH interview: Inflexion – Building better healthcare outcomes in the European Mid-Market
Private equity investing in healthcare requires not only capital but sector expertise, strategic foresight, and an ability to partner with management teams over long investment horizons. With a dedicated healthcare […]
Private equity investing in healthcare requires not only capital but sector expertise, strategic foresight, and an ability to partner with management teams over long investment horizons. With a dedicated healthcare […]
IIH interview: Inflexion – Building better healthcare outcomes in the European Mid-Market
October 20, 2025
Analysis
Healthcare
Life Sciences
News
Pharma
India: L Catterton invests in Healing Hands to support network expansion
L Catterton, a consumer-focused investment firm, has made an investment in Healing Hands Clinic, the largest proctology-focused specialist clinic chain in India. The investment from L Catterton – the company’s only […]
L Catterton, a consumer-focused investment firm, has made an investment in Healing Hands Clinic, the largest proctology-focused specialist clinic chain in India. The investment from L Catterton – the company’s only […]
India: L Catterton invests in Healing Hands to support network expansion
October 20, 2025
Healthcare
Hospitals and Clinics
News
Venture
Ashwin Porwal
The latest insights from
Compass Carter Osborne
Culture in flux: rebuilding trust in a multi-generational workforce
Culture in flux: rebuilding trust in a multi-generational workforce
October 24, 2025
Healthcare
Insight
